Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2459173 Title: COMPOSITIONS PHARMACEUTIQUES UTILISABLES DANS LE CADRE DU TRAITEMENT DU CANCER ET D'AUTRES MALADIES OU AFFECTIONS

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
107394132
WO application number:
US2010002109
Type:
European patent granted for BE
Status:
Lapsed
Publication number:
2459173
WO publication number:
WO2011014248
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
28/07/2010
Grant date:
28/02/2018
EP publication date:
06/06/2012
WO publication date:
03/02/2011
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
28/02/2018
EP B1 publication date:
28/02/2018
EP B2 publication date:
EP B3 publication date:
Lapsed date:
31/07/2018
Expiration date (if granted and all annual fees paid):
28/07/2030

Applicant

Name:
Millennium Pharmaceuticals, Inc.
Legal Form:
From:
28/02/2018
Address:
40 Landsdowne Street, Cambridge, MA 02139, United States (US)
To:

Inventor

1

Name:
RAMANAN, Vijayalakshmi
Legal Form:
Address:
Sharon MA 02067, United States (US)

2

Name:
TOBIAS, Irene Sophie
Legal Form:
Address:
Cambridge MA 02142, United States (US)

3

Name:
VERWIJS, Dauntel Specht
Legal Form:
Address:
Framingham MA 01701, United States (US)

4

Name:
SKWIERCZYNSKI, Raymond D.
Legal Form:
Address:
Andover MA 01810, United States (US)

Priority

Priority patent number:
230212 P
Priority date:
31/07/2009
Priority country:
United States (US)

Classification

IPC or IDT classification:
A61K 9/08; A61K 31/55; A61K 9/00; A61P 35/00;

Publication

Bulletin

1

Bulletin heading:
EP2
Journal edition number:
2018/04
Publication date:
14/03/2018
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

2

Bulletin heading:
VRV
Journal edition number:
2019/07
Publication date:
01/04/2019
Description:
Contains data concerning lapse, annulment or rejection of patent(s) (applications) and SPC (applications)

European Patent Bulletin

Issue number:
201809
Publication date:
28/02/2018
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
Annual fee number:
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type